These results, together with a preceding report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the strategy of concentrating on ACKR3 as a novel method to modulate the opioid process, which could open up new therapeutic avenues for opioid-relevant Problems. Conolidine claims being a https://creightonx062vng9.activoblog.com/profile